Taylor Haines
Family Medicine · Mooresville, NCNPI 1467089474
Payments from drug & device makers
Across 90 payments — averaging $20.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$556
- AbbVie$209
- Amgen$134
- Axsome Therapeutics, Inc.$133
- AstraZeneca$125
- Lilly USA, LLC$92
- plus $554 from 15 others
What the payments were for
- Food & beverage$1,802100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 25 | $556 |
| AbbVie | 16 | $209 |
| Amgen | 6 | $134 |
| Axsome Therapeutics, Inc. | 6 | $133 |
| AstraZeneca | 7 | $125 |
| Lilly USA, LLC | 5 | $92 |
| Astellas Pharma US Inc | 3 | $66 |
| Warner-lambert Company LLC | 1 | $60 |
| GSK | 3 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $50 |
| Pfizer | 2 | $47 |
| Cranial Technologies, Inc | 2 | $46 |
| Dexcom, Inc. | 2 | $43 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $35 |
| Phathom Pharmaceuticals, Inc. | 2 | $30 |
| Abbott | 1 | $25 |
| Mayne Pharma Commercial LLC | 1 | $24 |
| Inari Medical, Inc. | 1 | $23 |
| Novartis | 1 | $21 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ozempic$107
How this compares
$1,802 in reported general payments places this provider in the 75th percentile of 3,444 family medicine providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mirtazapine | 21 | $846 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 16 | $558 |
| Rosuvastatin Calcium | 26 | $350 |
| Metformin Hcl | 41 | $299 |
| Omeprazole | 21 | $262 |
| Levothyroxine Sodium | 21 | $238 |
| Warfarin Sodium | 12 | $165 |
| Losartan Potassium | 22 | $154 |
| Pantoprazole Sodium | 15 | $150 |
| Lisinopril | 26 | $124 |
| Atorvastatin Calcium | 16 | $108 |
| Furosemide | 23 | $99 |
| Hydrochlorothiazide | 15 | $74 |
| Amlodipine Besylate | 14 | $59 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Mooresville
- Bruce SeatonMooresville$1.9M
- Rebecca AppletonMooresville$538K
- Timothy BarkerMooresville$200K
- Barton WilliamsWilmington$17.3M
- Alexander MurrayGreensboro$13M
- Arin PiramzadianJacksonville$13M
- Jonathan WilsonHickory$12.7M
- George RaadCharlotte$7.7M
- Cecil FarringtonSalisbury$6.4M
- Christian MartinShelby$5.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.